Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HDAC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
STRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP7-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORCS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AWAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on